Communication to industry – SAHPRA Statement on Regulation of Category D Medicines

Communication to industry – SAHPRA Statement on Regulation of Category D Medicines

In response to the Supreme Court of Appeal (SCA) judgment on 11 April 2022 regarding the Alliance of Natural Health Products (ANHP), the Minister of Health recently released, for public comment, draft amendments to the General Regulations made in terms of the Medicines and Related Substances Act, 1965 (Act 101 of 1965) on 24 March 2023.

Download latest version
Version: 1
Date Updated: 02/06/2023
File Type: pdf
Category: Communication to industry
Unit: Complementary Medicines